Detalhe da pesquisa
1.
Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2-3 trial.
Lancet Oncol
; 18(3): 357-370, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28163000
2.
Role of nutritional status and intervention in oesophageal cancer treated with definitive chemoradiotherapy: outcomes from SCOPE1.
Br J Cancer
; 115(2): 172-7, 2016 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27328311
3.
Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial.
Lancet Oncol
; 14(7): 627-37, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23623280
4.
Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trial.
EClinicalMedicine
; 61: 102059, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37409323
5.
Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial.
Lancet Gastroenterol Hepatol
; 8(11): 1015-1027, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37734399
6.
The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy.
Radiother Oncol
; 125(1): 154-159, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28893415
7.
Potential of Proton Therapy to Reduce Acute Hematologic Toxicity in Concurrent Chemoradiation Therapy for Esophageal Cancer.
Int J Radiat Oncol Biol Phys
; 99(3): 729-737, 2017 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29280467
8.
The influence of dose distribution on treatment outcome in the SCOPE 1 oesophageal cancer trial.
Radiat Oncol
; 11: 19, 2016 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26852238
9.
An Analysis of Plan Robustness for Esophageal Tumors: Comparing Volumetric Modulated Arc Therapy Plans and Spot Scanning Proton Planning.
Int J Radiat Oncol Biol Phys
; 95(1): 199-207, 2016 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27084641
10.
The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: a radiobiological investigation.
Radiat Oncol
; 10: 236, 2015 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26586375
11.
Radiobiological determination of dose escalation and normal tissue toxicity in definitive chemoradiation therapy for esophageal cancer.
Int J Radiat Oncol Biol Phys
; 90(2): 423-9, 2014 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25304796
12.
Challenging disease, challenging trial, challenging interpretation.
Lancet Gastroenterol Hepatol
; 3(2): 78-79, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29248398
13.
Malignant melanoma (non-metastatic).
Clin Evid
; (14): 2058-72, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16620482
14.
Malignant melanoma (non-metastatic).
Clin Evid
; (9): 1842-53, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15366205
15.
Malignant melanoma (non-metastatic).
Clin Evid
; (10): 1897-909, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15555184
16.
Malignant melanoma (non-metastatic).
Clin Evid
; (12): 2321-35, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15865791
17.
Malignant melanoma: non-metastatic.
Clin Evid
; (7): 1519-29, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12230768
18.
Study to determine adequate margins in radiotherapy planning for esophageal carcinoma by detailing patterns of recurrence after definitive chemoradiotherapy.
Int J Radiat Oncol Biol Phys
; 73(3): 818-23, 2009 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18718726